“The Complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts, about the Company's business and operations. Specifically, the Complaint alleges that Defendants downplayed pressures on the Company's adjusted EPS resulting from increased medical costs associated with pent-up demand for healthcare procedures (especially as COVID concerns abated) which, contrary to the Company's assurances, resulted in increased utilization rates and costs. As a result of the Defendants' alleged wrongful acts and omissions, there was a significant decline in the market value of the Company's common stock pursuant to the revelation of the fraud.”
https://www.businesswire.com/news/home/20240605302144/en/HUM-INVESTOR-ALERT-Bronstein-Gewirtz-Grossman-LLC-Announces-that-Humana-Inc.-Investors-with-Substantial-Losses-Have-Opportunity-to-Lead-Class-Action-Lawsuit%21